This page contains a compilation of Rel/NF-kappaB target genes that is derived from the survey paper Activators and target genes of Rel/NF-kappaB transcription factors (Pahl, Oncogene 1999), the Rel/NF-kappaB transcription factors website of TD Gilmore, and additional search with PubMed. We distinguish four groups of genes: Human genes with checked binding sites (there is a strong experimental evidence of Rel/NF-kappaB direct control, such as chromatin immunoprecipitation or promoter transactivation), putative Human genes, checked genes in orthologous species (mouse, rat , rabbit), and putative genes in orthologous species.
For each entry, the following information is available
[File containing all Human identifiers]
[File containing all Mouse identifiers]
PubMed | Name | Description | OMIM | Species | RefSeq (Human) | Promoter | Ortholog (Mouse) | Site location | Site sequence |
Human genes with checked binding sites | |||||||||
11922943 | IGHG4 | immunoglobulin heavy constant gamma 4 (G4m marker) | 147130 | human | K01316 | K01316 | -65/-56 | ||
10760789 | IGHG3 | immunoglobulin heavy constant gamma 3 (G3m marker) | 147120 | human | M12958 | M12958 | |||
8036173 | APOC3 | apolipoprotein C-III | 107720 | human | NM_000040 | NM_000040 | NM_023114 | -159 | GGGATTTCCC |
10022897 | TNFRSF6 | tumor necrosis factor receptor superfamily, member 6 (cCD95 Fas) | 134637 | human | NM_000043 | NM_000043 | NM_007987 | -295/-286 | GGGCGTTCCC |
12374807 | CD3G | T-cell receptor/CD3gamma, CD3G antigen, gamma polypeptide (TiT3 complex) | 186740 | human | NM_000073 | NM_000073 | NM_009850 | -124/-120, +450/+454 | GGAAA, GGAAA |
11751888 | TNFSF5 | t CD40L tumor necrosis factor (ligand) superfamily, member 5 (hyper-IgM syndrome) | 300386 | human | NM_000074 | NM_000074 | NM_011616 | -1191/-1181 and in the 3' flanking region 946/-956 | GGGATTTCCA, GGAATTTTCC |
9845534 | CD105 | endoglin (Osler-Rendu-Weber syndrome 1) (ENG) | 131195 | human | NM_000118 | NM_000118 | NM_007932 | -218/-210 | GGGGCTCCC |
8970974 | ICAM1 | intercellular adhesion molecule 1 (CD54), human rhinovirus receptor | 147840 | human | NM_000201 | NM_000201 | NM_010493 | -185/-177 | GGAAATTCC |
12208876 | TPMT | thiopurine S-methyltransferase | 187680 | human | NM_000367 | NM_000367 | NM_016785 | -692/-683 | GGGAATTCCC |
1508203 | IL2RA | i IL-2 receptor alpha chain interleukin 2 receptor, alpha chain | 147730 | human | NM_000417 | NM_000417 | NM_008367 | -267/-258 | GGGAATCTCC |
1710341 | SELE | selectin E (endothelial adhesion molecule 1) ELAM1 | 131210 | human | NM_000450 | NM_000450 | NM_011345 | -135,-164, -145 | GGGGATTTCC, GATATTCC, GGATG |
8051093 | TP53 | tumor protein p53 (Li-Fraumeni syndrome) | 191170 | human | NM_000546 | NM_000546 | NM_011640 | +49/+68 | GGGGTTTTCC |
11035101 | CRP | C-reactive protein, pentraxin-related | 123260 | human | NM_000567 | NM_000567 | NM_007768 | -50/-41 | AAACTCCCTT |
8605359 | IL1A | interleukin 1, alpha | 147760 | human | NM_000575 | NM_000575 | NM_010554 | -1065/-1056, +646/+655 | GGGGCATGCC, GGGGCTCCCC |
8413223 | IL1B | interleukin 1, beta | 147720 | human | NM_000576 | NM_000576 | NM_008361 | -300/-289 | GGGAAAATCC |
7930581 | IL1RN | interleukin 1 receptor antagonist | 147679 | human | NM_000577 | NM_000577 | NM_031167 | -93/-84 | GGGTATTTCC |
9840284 | CCR5 | chemokine (C-C motif) receptor 5 | 601373 | human | NM_000579 | NM_000579 | NM_009917 | -682 | GTGAAAATCCC |
8207232 | IL8 | interleukin 8 | 146930 | human | NM_000584 | NM_000584 | -82/-72 | GTGGAATTTCC | |
2497518 | IL2 | interleukin 2 | 147680 | human | NM_000586 | NM_000586 | NM_008366 | -206/-195 | AGGGATTTCACC |
8663174 | IL9 | interleukin 9 | 146931 | human | NM_000590 | NM_000590 | NM_008373 | -59/-50 | GGGTTTTTCC |
7699330 | TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 170260 | human | NM_000593 | NM_000593 | NM_013683 | -38/-47 from the third major start site upstream from the ATG | GGGACTTTCC |
2104921+1715367+2263628 | TNF | tumor necrosis factor (TNF superfamily, member 2) TNF alpha | 191160 | human | NM_000594 | NM_000594 | NM_013693 | -579/-586,-202/-211,-99/-89 | GGGACAGCCC, GGGGTATCC, GGGTTTCTCC |
9541585 | LTA | lymphotoxin alpha (TNF superfamily, member 1) | 153440 | human | NM_000595 | NM_000595 | NM_010735 | -99/-89 | GGGGGCTTCCC |
8972179 | IL6 | interleukin 6 (interferon, beta 2) | 147620 | human | NM_000600 | NM_000600 | -73/-63 | GGGATTTTCCC | |
12208876 | CD44 | CD44 antigen (homing function and Indian blood group system) | 107269 | human | NM_000610 | NM_000610 | +87/+97 | GGGATCCTCC | |
8607810 | NOS2A | nitric oxide synthase 2A (inducible, hepatocytes) | 163730 | human | NM_000625 | NM_000625 | NM_010927 | -115/-106 | GGGACACTCC |
10492402 | SOD2 | MnSOD, superoxide dismutase 2, mitochondrial | 147460 | human | NM_000636 | NM_000636 | NM_013671 | -350/-341, -1420/-1411,+2759/+2768 | GGGTCTTCCC, GGGGCTTTCC, GGGAATACCC |
10744679 | TNFSF6 | tumor necrosis factor (fas ligand) superfamily, member 6 | 134638 | human | NM_000639 | NM_000639 | NM_010177 | -1088 | |
9191851 | IL11 | interleukin 11 | 147681 | human | NM_000641 | NM_000641 | NM_008350 | -690 | TCGGGGTCTCCCTGGGTCTCCCAA |
9446586 | BDKRB1 | bradykinin receptor B | 600337 | human | NM_000710 | NM_000710 | NM_007539 | -64/-55 | GGCAATCCC |
1912581 | CSF1 | colony stimulating factor 1 (macrophage) (M-CSF) | 120420 | human | NM_172212 | NM_172212 | NM_007778 | -377/-368 | GGGACTTTCC |
2406568+11418664 | CSF2 | colony stimulating factor 2 (granulocyte-macrophage) (IGM-CSF) | 138960 | human | NM_000758 | NM_000758 | NM_009969 | -86/-77, -101/-92 | AGGTAGTTCC, GAGATTCCAC |
7513199 | CSF3 | colony stimulating factor 3 (granulocyte) (G-CSF) | 138970 | human | NM_000759 | NM_000759 | NM_009971 | -179/-188 | GAGATTCCAC |
8546677 | GSTP1 | glutathione S-transferase pi | 134660 | human | NM_000852 | NM_000852 | NM_013541 | -96/-86 | GGGACCCTCC |
9058597 | NQO1 | NAD(P)H dehydrogenase, quinone 1 | 125860 | human | NM_000903 | NM_000903 | NM_008706 | -830/-820 | GGGGCTTCAC |
14500744 | OPRM1 | opioid receptor, mu 1 | 600018 | human | NM_000914 | NM_000914 | NM_011013 | -1968, -352, -2 | GGGACTTTCA, GGGGTTTTAG, GGGGCTATAC |
10403752 | PTAFR | platelet-activating factor receptor | 173393 | human | NM_000952 | NM_000952 | -1099/-610 | ||
9514889+12471036 | PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (COX-2) | 600262 | human | NM_000963 | NM_000963 | NM_011198 | -438/-447, -231/-222 | GGGGATTCCC, GGGACTACCC |
12023897 | SCNN1A | Amiloride-sensitive sodium channel, nonvoltage-gated 1 alpha | 600228 | human | NM_001038 | NM_001038 | NM_011324 | -506 | CCTTGGAGGG |
1379595 | VCAM1 | vascular cell adhesion molecule 1 | 192225 | human | NM_001078 | NM_001078 | NM_011693 | -77/-68, -63/-54 | GGGTTTCCCC, AGGGATTTCCC |
10829018, 9195959 | AGER | advanced glycosylation end product-specific receptor | 600214 | human | NM_172197 | NM_172197 | NM_007425 | -671/-663 ,-1518/-1510 | GAGAAACCCC, GGGAACCCCT |
7729529 | ALOX12B | arachidonate 12-lipoxygenase, 12R type | 603741 | human | NM_000697 | NM_000697 | NM_009659 | -505 | GGGACATCCC |
12226754 | BCL2L1 | BCL2-like 1 | 600039 | human | NM_001191 | NM_001191 | NM_009743 | -341/-350, -357/-366, -59/-84 | GTGACTTTCC, GGGGACTGCC, GGGACTGCCC |
11313274 | TNFRSF5 | tumor necrosis factor receptor superfamily, member 5 (CD40) | 109535 | human | NM_001250 | NM_001250 | NM_011611 | -576/-566, -468/-458, -174/-164 | GGGAATTTCC, GGGAACTTCC, GGGAAACTCC |
12706838 | TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 (CD137) | 602250 | human | NM_001561 | NM_001561 | NM_011612 | -89/-77 | GTGGGAATTTCCCA |
11877397 | IRF7 | interferon regulatory factor 7 | 605047 | human | NM_004030 | NM_004030 | NM_016850 | -51/-60 | GGAAACTCC |
9786883 | BLR1 | Burkitt lymphoma receptor 1, GTP binding protein (chemokine (C-X-C motif) receptor 5 CXCR5) | 601613 | human | NM_001716 | NM_001716 | NM_007551 | +44/+54 +2 other sites located between -612/-1 | GGGATTTTCCC, GGAGTTTCCC, GGGGTTTCCCA |
7815555 | CD48 | CD48 antigen (B-cell membrane protein) | 109530 | human | NM_001778 | NM_001778 | NM_007649 | -1149/-1133 | GGAAGGGGCTTTCCCCA |
7665567 | CD69 | CD69 antigen (p60, early T-cell activation antigen) | 107273 | human | NM_001781 | NM_001781 | -373,-223,-160 | GGGAAAACCC | |
12208876 | CCR7 | chemokine (C-C motif) receptor 7 | 600242 | human | NM_001838 | NM_001838 | NM_007719 | -350/-341, -223/-214 | GGGACACTTC, GGGGCTTTTT |
12444129 | CR2 | complement receptor 2 : complement component (3d/Epstein Barr virus) receptor 2 | 120650 | human | NM_001877 | NM_001877 | NM_007758 | -531/-509 | AGTATATGGGAATTCTCTGCAGT |
1744583 | F3 | coagulation factor III (thromboplastin, tissue factor) | 134390 | human | NM_001993 | NM_001993 | NM_010171 | -188 | GGGAGTTTCC |
8016102 | HMOX1 | heme oxygenase (decycling) 1 | 141250 | human | NM_002133 | NM_002133 | NM_010442 | -173/-152 | GACTTTGTTTCCCAAGGGTCA |
9154819 | TNC | tenascin C (hexabrachion) | 187380 | human | NM_002160 | NM_002160 | NM_011607 | -219/-210 | GGGAATTCCT |
2542571 | IFNB1 | interferon, beta 1, fibroblast | 147640 | human | NM_002176 | NM_002176 | NM_010510 | -64/-55 | GGGAAATTCC |
12208876 | IL13 | interleukin 13 | 147683 | human | NM_002188 | NM_002188 | NM_008355 | -1291/-1282, -1082/-1073 | GGGATGCCTC, GGGGGTTTCT |
11160322 | IL15RA | interleukin 15 receptor, alpha | 601070 | human | NM_172200 | NM_172200 | NM_008358 | -989/-979 | GGGATTTCCC |
7507207 | IRF1 | interferon regulatory factor 1 | 147575 | human | NM_002198 | NM_002198 | NM_008390 | -47/-38 | GGGGAATCCC |
7507207 | IRF2 | interferon regulatory factor 2 | 147576 | human | NM_002199 | NM_002199 | NM_008391 | -33/-24 | GGGGATTTCC |
8786306 | LTB | lymphotoxin beta (TNF superfamily, member 3) | 600978 | human | NM_009588 | NM_009588 | NM_008518 | -110/+1 | GGAAAGTCCC |
12218129 | IRF4 | interferon regulatory factor 4 | 601900 | human | NM_002460 | NM_002460 | NM_013674 | -445, -517 | GCGAAGTCCCC, GGGTGCTCCC |
11306700 | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 190080 | human | NM_002467 | NM_002467 | NM_010849 | -1329, 269 | AAGGGTCT, GGGGACAC |
7541912 | NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 164012 | human | NM_002502 | NM_002502 | NM_019408 | -377/-387, -95/-105, -68/-78, +701/+691, +955/+945, +1108/+1098 from the major start site | GGGGATCCCCC, GGGAATTCCC, GGGGCTTTCCG, GGGCCTCCC, GGGGCTTCCCG, GGGACTTTCC |
7635955 | PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 190040 | human | NM_002608 | NM_002608 | NM_011057 | -125/-115 | GAGACC |
10824110 | PLAU | urokinase-type plasminogen activator | 173391 | human | NM_002658 | NM_002658 | NM_008873 | -1865 et-1835, et-47 | GGGAATTTCC, GGGAGTTTC, GGGAGGAGTC |
7699330 | LMP2 | proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional protease 2) (PSMB9) | 177045 | human | NM_002800 | NM_002800 | NM_013585 | -407/-398 from the third major start site upstream from the ATG | GGGACTTTCC |
9079634 | PTX3 | pentaxin-related gene, rapidly induced by IL-1 beta | 602492 | human | NM_002852 | NM_002852 | -87/-97, -1126/-1136 | GGGGAACTCCC, CGGGATTTTCC | |
8051410, 9174597 | CCL2 | chemokine (C-C motif) ligand 2 (MCP1/JE) | 158105 | human | NM_002982 | NM_002982 | NM_011333 | -2600, -78 | GGGAATTTCC, GGAAGATCCC |
9120310 | CCL5 | chemokine (C-C motif) ligand 5 (RANTES) | 187011 | human | NM_002985 | NM_002985 | -40,-54,-221,-590 | GGGGATGCCC, GGAAACTCCC, AGAAATTTTTCC, AGAAATTCCC | |
11076795 | CCL11 | chemokine (C-C motif) ligand 11 | 601156 | human | NM_002986 | NM_002986 | NM_011330 | -68/-60 | GGAATCTCCC |
11559712 | CXCL5 | Neutrophil activating peptide-78, chemokine (C-X-C motif) ligand 5 | 600324 | human | NM_002994 | NM_002994 | NM_009141 | -82/-91 | CAGGGAATTTCCCCA |
7559449 | SELP | selectin P (granule membrane protein 140kDa, antigen CD62) | 173610 | human | NM_003005 | NM_003005 | NM_011347 | -123 | GGGGGTGACCCC |
12208876 | SLC2A5 | solute carrier family 2 (facilitated glucose/fructose transporter), member 5 (GLUT5) | 138230 | human | NM_003039 | NM_003039 | NM_019741 | -194/-185, -142/-133 | GGGAAATACC, GGGGGCACCC |
12208876+12208876 | STAT5A | signal transducer and activator of transcription 5A | 601511 | human | NM_003152 | NM_003152 | NM_011488 | -127/-118, -40/-31 | GGGGAGGCC, GGGGCCTCTT |
8420985 | VIM | vimentin | 193060 | human | NM_003380 | NM_003380 | NM_011701 | -217/-226 | GGGGCTTTCC |
12360408 | IER3 | immediate early response 3 (IEX-1L) | 602996 | human | NM_003897 | NM_003897 | NM_133662 | -102/-92 | CGGAATTTCC |
1740105 | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) | 164011 | human | NM_003998 | NM_003998 | NM_008689 | -304 | GGGGGCTTCCC |
12480693 | BM2 | beta-2-microglobulin | 109700 | human | NM_004048 | NM_004048 | -96 | GGGAAAGTCCC | |
10049353 | BCL2A1 | BCL2-related protein A1 | 601056 | human | NM_004049 | NM_004049 | NM_009742 | -833/-823 | GGGGATTTACC |
12414801 | CCL15 | chemokine (C-C motif) ligand 15 (MIP-3alpha) | 601393 | human | NM_004591 | NM_004591 | -92 | GGGAAAACCC | |
11275263+12182451 | CD83 | CD83 antigen (activated B lymphocytes, immunoglobulin superfamily) | 604534 | human | NM_004233 | NM_004233 | NM_009856 | 0/-261 | |
8164652 | CD74 | CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) | 142790 | human | NM_004355 | NM_004355 | NM_010545 | -109/-118, -163/-172 | GGGGTATTTCC, GGGGAGCCCC |
12746898 | ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) (ESE-1) | 602191 | human | NM_004433 | NM_004433 | NM_007921 | -88/-79 | GGAAATCCCC |
9486175 | TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 190196 | human | NM_004613 | NM_004613 | NM_009373 | -1338 | |
12958190 | DEFB4 | defensin, beta 4 | 602056 | human | NM_004942 | NM_004942 | NM_019728 | -175/-167, -165/-157 relative to the TATA box | GGGATTTTC, GGGGTTTCC |
8631874 | MMP9 | matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 120361 | human | NM_004994 | NM_004994 | NM_013599 | -600/-610 | GGGGGTTGCCCC |
11387332 | BCL3 | B-cell CLL/lymphoma 3 | 109560 | human | NM_005178 | NM_005178 | NM_033601 | -937, -171 | AGGATTTTCCGA, TCCTTTGGGA |
8642282+890682 | CD80 | CD80 antigen (CD28 antigen ligand 1, B7-1 antigen) | 112203 | human | NM_005191 | NM_005191 | NM_009855 | -2977/-2967 | GGGGTTTTCCC |
12471041 | VEGF C | vascular endothelial growth factor C | 601528 | human | NM_005429 | NM_005429 | NM_009506 | +401/+410 | GGGGGTCGCC |
14550290 | PLCD1 | phospholipase C, delta 1 | 602142 | human | NM_006225 | NM_006225 | NM_019676 | -1306/-1288 | GGGACTTTCC |
1381359 | TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 (A20) | 191163 | human | NM_006290 | NM_006290 | NM_009397 | -239, -251 | GGAAATCCCC, GGAAAGTCCC |
11753650 | RELB | v-rel reticuloendotheliosis viral oncogene homolog B, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 (avian) | 604758 | human | NM_006509 | NM_006509 | NM_009046 | from ATG -247/-238, -175/-166 (-114=1rst main TSS, -126= 2nd main TSS) | GGGGTTTTCC, GGGGAATTCC |
11978801+12208876 | TFPI2 | tissue factor pathway inhibitor 2 | 600033 | human | NM_006528 | NM_006528 | NM_009364 | -234/-225 | GGGGAATTCC |
12835724+10733571 | BCL2 | B-cell CLL/lymphoma 2 | 151430 | human | NM_000657 | NM_000657 | NM_009741 | -180 (ou -28) | GGGAAACACC |
12859951 | S100A6 | S100 calcium binding protein A6 (calcyclin) | 114110 | human | NM_014624 | NM_014624 | NM_011313 | -460/-451 | GGGAGTAGCC |
12594338 | TACR1 | tachykinin receptor 1, neurokinin 1 receptor (NK-1R) | 162323 | human | NM_015727 | NM_015727 | NM_009313 | -532/-543 | GGGTGTTTCC |
12208876 | NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 164008 | human | NM_020529 | NM_020529 | NM_010907 | -319/-310, -225/-216, -63/-53 | GGAAACCC, GGGAGGACTTTC, GGAAATTCCCC |
12957386 | CD209 | antigen (DC-SIGN) | 604672 | human | NM_021155 | NM_021155 | NM_133238 | +426/+433 of the fourth TSS 5' from the ATG | AGGGTGGG |
12194982 | CARD15 | caspase recruitment domain family, member 15 (Nod2) | 605956 | human | NM_022162 | NM_022162 | NM_145857 | -25 | GGGAATTTCC |
10082535+10409765 | CCND1 | cyclin D1 (PRAD1: parathyroid adenomatosis 1) | 168461 | human | NM_053056 | NM_053056 | NM_007631 | -806, 13 | GGGGACCCC, GGGGAGTTTT |
11909978 | KLK3 | kallikrein 3, (prostate specific antigen) | 176820 | human | NM_145864 | NM_145864 | 4 sites located in an enhancer at -4366/-3824 | TGCCCCCCCC, GGGGTTTGTG, GGGACAACTT, GGTGGTGCTG | |
9482906 | IL15 | interleukin 15 | 600554 | human | NM_172174 | NM_172174 | NM_008357 | -212 | GGGGCTCCT |
11884470 | NR4A2 | nuclear receptor subfamily 4, group A, member 2 (NURR1) | 601828 | human | NM_173173 | NM_173173 | NM_013613 | -585/-576 | GGGAAATCCC |
10867022 | HC3 | proteasome subunit alpha-type 2 (PSMA2) | human | NM_002787 | NM_002787 | NM_008944 | -304, -324 | GGAAGCTTCC, CCTTTCGGG | |
Checked binding sites - other species | |||||||||
serum amyloid A3 | mouse | ||||||||
Complement B | mouse | ||||||||
H+-K+ATPase alpha2 | mouse | ||||||||
PKCdelta | mouse | ||||||||
Pregnancy-specific glycoprotein rnCGM3 | rat | ||||||||
Serpin 2A | mouse | ||||||||
AR | androgen receptor (dihydrotestosterone receptor; Testicular feminization; Spinal and bulbar muscular atrophy; Kennedy disease) | 313700 | rat | NM_000044 | NM_000044 | NM_013476 | |||
SERPINA1 | alpha antitrypsin, serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 (SERPINA1) | 107400 | rabbit | NM_000295 | NM_000295 | NM_009245 | |||
AMH | anti-Mullerian hormone | 600957 | mouse | NM_000479 | NM_000479 | NM_007445 | |||
ADH1A | alcohol dehydrogenase 1A (class I), alpha polypeptide | 103700 | rat | NM_000667 | NM_000667 | NM_007409 | |||
NPY1R | neuropeptide Y receptor Y1 | 162641 | mouse | NM_000909 | NM_000909 | NM_010934 | |||
ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | 171050 | rat or mouse | NM_000927 | NM_000927 | NM_011076 | |||
PTGDS | Lipocalin-type prostaglandin D synthase : prostaglandin D2 synthase 21kDa (brain) | 176803 | rat | NM_000954 | NM_000954 | NM_008963 | |||
BMP2 | bone morphogenetic protein 2 | 112261 | mouse | NM_001200 | NM_001200 | NM_007553 | |||
CASP4 | caspase 4, apoptosis-related cysteine protease | 602664 | mouse | NM_001225 | NM_001225 | NM_007609 | |||
TBR | T cell receptor beta locus | 186930 | mouse | NM_001333 | NM_001333 | NM_009984 | |||
CXCL10 | chemokine (C-X-C motif) ligand 10 (IP-10) | 147310 | mouse | NM_001565 | NM_001565 | NM_021274 | |||
FN1 | fibronectin 1 | 135600 | rat | NM_002026 | NM_002026 | ||||
FTH1 | ferritin H chain, heavy polypeptide 1 | 134770 | rat | NM_002032 | NM_002032 | NM_010239 | |||
CXCL2 | chemokine (C-X-C motif) ligand 2 (MIP2) | 139110 | mouse | NM_002089 | NM_002089 | NM_009140 | |||
CXCL9 | chemokine (C-X-C motif) ligand 9 | 601704 | mouse | NM_002416 | NM_002416 | NM_008599 | |||
CCL4 | chemokine (C-C motif) ligand 4 (MIP1beta) | 182284 | mouse | NM_002984 | NM_002984 | NM_013652 | |||
SIAT8A | sialyltransferase 8A (alpha-N-acetylneuraminate: alpha-2,8-sialyltransferase, GD3 synthase) | 601123 | mouse | NM_003034 | NM_003034 | NM_011374 | |||
TERT | telomerase reverse transcriptase | 187270 | mouse | NM_003219 | NM_003219 | NM_009354 | |||
ARFRP1 | ADP-ribosylation factor related protein 1 | 604699 | mouse | NM_003224 | NM_003224 | NM_029702 | |||
MYB | v-myb myeloblastosis viral oncogene homolog (avian) | 189990 | mouse | NM_005375 | NM_005375 | NM_010848 | |||
PENK | proenkephalin | 131330 | rat | NM_006211 | NM_006211 | ||||
PLA2G4 | phospholipase A2, group IVA (cytosolic, calcium-dependent) | 600522 | rat | NM_024420 | NM_024420 | NM_008869 | |||
608004 | mouse | NM_031419 | NM_031419 | NM_030612 | |||||
MADCAM1 | mucosal vascular addressin cell adhesion molecule 1 | 102670 | mouse | NM_130760 | NM_130760 | NM_013591 | |||
TAPBP | TAP binding protein (tapasin) | 601962 | mouse | NM_172209 | NM_172209 | NM_009318 | |||
Putative Human target genes | |||||||||
12505312 | CYP2C11 | human | |||||||
NK4 | human | ||||||||
2106065 | AGT | angiotensinogen (serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 8) | 106150 | human | NM_000029 | NM_000029 | NM_007428 | ||
12513753 | WT1 | Wilms tumor 1 | 607102 | human | NM_000378 | NM_000378 | NM_144783 | ||
10098886 | G6PD | glucose-6-phosphate dehydrogenase | 305900 | human | NM_000402 | NM_000402 | NM_008062 | ||
12471121 | IL10 | interleukin 10 | 124092 | human | NM_000572 | NM_000572 | NM_010548 | ||
ORM1 | orosomucoid 1, alpha-1 acid glycoprotein | 138600 | human | NM_000607 | NM_000607 | NM_008768 | |||
9547356 | ADORA1 | adenosine A1 receptor | 102775 | human | NM_000674 | NM_000674 | |||
2550553 | C4BPA | complement component 4 binding protein, alpha | 120830 | human | NM_000715 | NM_000715 | NM_007576 | ||
12482504 | EPO | erythropoietin | 133170 | human | NM_000799 | NM_000799 | NM_007942 | ||
12411322 | BIRC2 | baculoviral IAP repeat-containing 2 | 601712 | human | NM_001166 | NM_001166 | NM_007465 | ||
9990294 | HAS1 | hyaluronan synthase 1 | 601463 | human | NM_001523 | NM_001523 | NM_008215 | ||
12070780 | FCER2 | Fc epsilon receptor II(CD23), Fc fragment of IgE, low affinity II, receptor for (CD23A) | 151445 | human | NM_002002 | NM_002002 | NM_013517 | ||
12388107 | FN1 | fibronectin 1 | 135600 | human | NM_002026 | NM_002026 | |||
10874048 | JUNB | jun B proto-oncogene | 165161 | human | NM_002229 | NM_002229 | NM_008416 | ||
8623933 | LGALS3 | lectin, galactoside-binding, soluble, 3 (galectin 3) | 153619 | human | NM_002306 | NM_002306 | NM_010705 | ||
12483727 | MMP8 | matrix metalloproteinase 8 (neutrophil collagenase) | 120355 | human | NM_002424 | NM_002424 | NM_008611 | ||
12237307+12077118 | MUC2 | mucin 2, intestinal/tracheal | 158370 | human | NM_002457 | NM_002457 | |||
11777968 | PIM1 | pim-1 oncogene | 164960 | human | NM_002648 | NM_002648 | NM_008842 | ||
2284104 | REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) (c-rel) | 164910 | human | NM_002908 | NM_002908 | NM_009044 | ||
11342414 | CCL3 | chemokine (C-C motif) ligand 3 (MIP1alpha) | 182283 | human | NM_002983 | NM_002983 | NM_011337 | ||
12378635 | CCL4 | chemokine (C-C motif) ligand 4 (aka LAG-1) | 182284 | human | NM_002984 | NM_002984 | NM_013652 | ||
11875461+11359904 | CFLAR | caspase-8-c-FLIP (flice inhibitory protein) and FADD-like apoptosis regulator | 603599 | human | NM_003879 | NM_003879 | NM_009805 | ||
11875461 | BAX | BCL2-associated X protein | 600040 | human | NM_004324 | NM_004324 | NM_007527 | ||
12133954 | PRF1 | perforin 1 (pore forming protein) | 170280 | human | NM_005041 | NM_005041 | NM_011073 | ||
11942414 | HBE1 | hemoglobin, epsilon 1 | 142100 | human | NM_005330 | NM_005330 | |||
9733516 | TRAF1 | TNF receptor-associated factor 1 | 601711 | human | NM_005658 | NM_005658 | NM_009421 | ||
12221085 | CCL7 | chemokine (C-C motif) ligand 7 (Mcp-3) | human | NM_006273 | NM_006273 | NM_013654 | |||
11875461 | TNFRSF21 | tumor necrosis factor receptor superfamily, member 21 (DR6) | 605732 | human | NM_014452 | NM_014452 | NM_178589 | ||
11713530 | GADD45B | growth arrest and DNA-damage-inducible, beta | 604948 | human | NM_015675 | NM_015675 | NM_008655 | ||
9733516 | TRAF2 | TNF receptor-associated factor 2 | 601895 | human | NM_021138 | NM_021138 | NM_009422 | ||
7968369 | PDYN | prodynorphin (preproenkephalin) | 131340 | human | NM_024411 | NM_024411 | NM_018863 | ||
7999086 | PLA2G4A | phospholipase A2, group IVA (cytosolic, calcium-dependent) | 600522 | human | NM_024420 | NM_024420 | NM_008869 | ||
Putative target genes - other species | |||||||||
C4B | complement component 4B | 120820 | rat | NM_000592 | NM_000592 | NM_009780 | |||
JUNB | jun B proto-oncogene | 165161 | mouse | NM_002229 | NM_002229 | NM_008416 | |||
MMP8 | matrix metalloproteinase 8 (neutrophil collagenase) | 120355 | rabbit | NM_002424 | NM_002424 | NM_008611 | |||
OLR1 | oxidised low density lipoprotein (lectin-like) receptor 1 (lox1) | 602601 | rat | NM_002543 | NM_002543 | NM_138648 | |||
LAMC2 | lamin chain beta, laminin, gamma 2 | 150292 | mouse | NM_005562 | NM_005562 | NM_008485 | |||
BCL2L10 | BCL2-like 10 (apoptosis facilitator) (Nr13) | 606910 | ? | NM_020396 | NM_020396 | NM_013479 | |||
608004 | mouse | NM_031419 | NM_031419 | NM_030612 | |||||
PKCdelta | mouse |